BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26753958)

  • 1. Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.
    Yu SY; Hong LC; Feng J; Wu YT; Zhang YZ
    Tumour Biol; 2016 Jul; 37(7):8923-30. PubMed ID: 26753958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
    Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
    World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative proteomics and transcriptomics revealed that activation of the IL-6R/JAK2/STAT3/MMP9 signaling pathway is correlated with invasion of pituitary null cell adenomas.
    Feng J; Yu SY; Li CZ; Li ZY; Zhang YZ
    Mol Cell Endocrinol; 2016 Nov; 436():195-203. PubMed ID: 27465831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.
    Gu YH; Feng YG
    J Clin Neurosci; 2018 Jan; 47():264-268. PubMed ID: 29031543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
    Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
    Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the proteomic variations of invasive relative to non-invasive non-functional pituitary adenomas.
    Zhan X; Desiderio DM; Wang X; Zhan X; Guo T; Li M; Peng F; Chen X; Yang H; Zhang P; Li X; Chen Z
    Electrophoresis; 2014 Aug; 35(15):2184-94. PubMed ID: 24729304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
    Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
    Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nkx3-1 and Fech genes might be switch genes involved in pituitary non-functioning adenoma invasiveness.
    Khayer N; Jalessi M; Jahanbakhshi A; Tabib Khooei A; Mirzaie M
    Sci Rep; 2021 Oct; 11(1):20943. PubMed ID: 34686726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
    Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
    Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
    Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
    J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.
    Joshi H; Vastrad B; Vastrad C
    J Mol Neurosci; 2019 Aug; 68(4):565-589. PubMed ID: 30982163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational analysis identifies invasion-associated genes in pituitary adenomas.
    Cao C; Wang W; Ma C; Jiang P
    Mol Med Rep; 2015 Aug; 12(2):1977-82. PubMed ID: 25824863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas.
    Liu D; Li J; Li N; Lu M; Wen S; Zhan X
    EPMA J; 2020 Sep; 11(3):419-467. PubMed ID: 32849927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas.
    Wang Y; Cheng T; Lu M; Mu Y; Li B; Li X; Zhan X
    EPMA J; 2019 Dec; 10(4):395-414. PubMed ID: 31832114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential circular RNA expression profiles of invasive and non-invasive non-functioning pituitary adenomas: A microarray analysis.
    Hu Y; Zhang N; Zhang S; Zhou P; Lv L; Richard SA; Ma W; Chen C; Wang X; Huang S; Jiang S
    Medicine (Baltimore); 2019 Jun; 98(26):e16148. PubMed ID: 31261542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas.
    Long Y; Lu M; Cheng T; Zhan X; Zhan X
    Front Endocrinol (Lausanne); 2019; 10():835. PubMed ID: 31920959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas.
    Kim YH; Kim JH
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):314-322. PubMed ID: 31565884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation profiling in nonfunctioning pituitary adenomas.
    Kober P; Boresowicz J; Rusetska N; Maksymowicz M; Goryca K; Kunicki J; Bonicki W; Siedlecki JA; Bujko M
    Mol Cell Endocrinol; 2018 Sep; 473():194-204. PubMed ID: 29410024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblasts play a potential role in bone destruction via osteopontin related caldesmon expression and polymerization in human non-functioning pituitary adenomas.
    Zhang LY; Ge XL; Li Z; Tang YJ; Xiong YY; Li XJ; Liu JF; Wanggou SY; Li CT; Yang K; Chen X; Hu ZL; Liu YS; Liu ZX
    Sci Rep; 2017 Dec; 7(1):17523. PubMed ID: 29235490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12-regulated miR-370-3p functions as a tumor suppressor gene by targeting HMGA2 in nonfunctional pituitary adenomas.
    Cai F; Dai C; Chen S; Wu Q; Liu X; Hong Y; Wang Z; Li L; Yan W; Wang R; Zhang J
    Mol Cell Endocrinol; 2019 May; 488():25-35. PubMed ID: 30853598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.